Insulin-like growth factors I and II in the aseptic loosening of total hip implants

Scandinavian Journal of Rheumatology

Volumn 33, Issue 6, 2004, Pages 428-431

  Waris, Ville ^a,b,g   Zhao, D S ^a   Leminen, H ^a   Santavirta, S ^c   Takagi, M ^d   Nordsletten, L ^e   Konttinen, Y T ^a,c,f  

^a UNIVERSITY OF HELSINKI   (Finland)

^b MIKKELI CENTRAL HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d YAMAGATA UNIVERSITY   (Japan)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; SOMATOMEDIN B; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MONOCYTE; OSSIFICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTHESIS LOOSENING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOTAL HIP PROSTHESIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; FEMALE; HIP PROSTHESIS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; JOINT INSTABILITY; MALE; MIDDLE AGED; PROGNOSIS; PROSTHESIS FAILURE; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SYNOVIAL MEMBRANE;

EID: 10844236269     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740410010254     Document Type: Article

References (11)

1. Wooley PH, Schwarz EM. Aseptic loosening. Gene Therapy 2004;11:402-7.
2. Jacobs JJ, Roebuck KA, Archibeck M, Hallab NJ, Giant TT. Osteolysis: basic science. Clin Orthop 2001;393:71-7.
3. Xu JW, Li TF, Partsch G, Ceponis A, Santavirta S, Konttinen YT. Interleukin-11 (IL-11) in aseptic loosening of total hip replacement (THR). Scand J Rheumatol 1998;27:363-7.
4. Konttinen YT, Waris V, Xu JW, Jiranek WA, Sorsa T, Virtanen I, et al. Transforming growth factor-beta 1 and 2 in the synovial-like interface membrane between implant and bone in loosening of total hip arthroplasty. J Rheumatol 1997;24:694-701.
5. Waris V, Xu JW, Nordsletten L, Sorsa S, Santavirta S, Konttinen YT. Basic fibroblast growth factor (bFGF) in the synovial-like membrane around loose total hip prostheses. Scand J Rheumatol 1996;25:257-62.
6. Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993;55:131-55.
7. Conover C. The Role of Insulin-Like Growth Factors and Binding Proteins in Bone Cell Biology. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology, 2ed. San Diego: Academic Press. 2002:225-37.
8. Bell GI, Merryweather JP, Sanchez-Pescador R, Stempien MM, Priestley L, Scott J, et al. Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature 1984;310:775-7.
9. Okazaki R, Conover CA, Harris SA, Spelsberg TC, Riggs BL. Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not. J Bone Miner Res 1995;10:788-95.
10. Steenbergh PH, Koonen-Reemst AM, Cleutjens CB, Sussenbach JS. Complete nucleotide sequence of the high molecular weight human IGF-I mRNA. Biochem Biophys Res Commun 1991;175:507-14.
11. Xu JW, Konttinen YT, Li TF, Waris V, Lassus J, Matucci-Cerinic M, et al. Production of platelet-derived growth factor in aseptic loosening of total hip replacement. Rheumatol Int 1998;17:215-21.